## **Core Concept**
The question tests the understanding of complications in leukemia patients, specifically those related to treatment. Leukaemia patients are prone to various treatment-related complications, including infections, due to their immunocompromised state, and cardiotoxicity from certain chemotherapeutic agents.

## **Why the Correct Answer is Right**
The correct answer, **C.**, implies that the likely cause is a condition known as **Pneumonitis or more specifically, Bleomycin-induced pulmonary toxicity**. Bleomycin is a chemotherapeutic agent used in the treatment of various types of cancer, including leukemia, lymphoma, and testicular cancer. One of its well-known side effects is pulmonary toxicity, which can manifest as pneumonitis and pulmonary fibrosis. This condition can present with symptoms such as chest pain, pulmonary infiltrates, and pleural effusion on imaging, matching the description given in the question.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option would be incorrect because, although infections can cause similar symptoms, the question hints at a treatment-related complication rather than an infectious aetiology.
- **Option B:** This option is incorrect because, while cardiotoxicity can lead to pulmonary oedema and pleural effusions, the combination of pulmonary infiltrates and the specific context points more towards a direct lung injury, such as pneumonitis.
- **Option D:** This option is incorrect as it does not directly relate to a well-known complication of chemotherapy that matches the symptoms described.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Bleomycin-induced pulmonary toxicity** is a dose-dependent side effect, and monitoring lung function tests is crucial in patients on bleomycin therapy. A classic clinical correlation is that this condition can be more severe with higher cumulative doses of bleomycin.

## **Correct Answer:** . **C. Bleomycin-induced pulmonary toxicity**